Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma
This is a non-interventional study to observe the safety and efficiency of chemotherapy for potentially resectable locally advanced esophagogastric junction
Esophagogastric Junction Cancer
disease free survival(DFS), time from surgery to disease recurrence or death, up to 3 years
Overall survival (OS), time to death, up to 5 years|Adverse events(AE), Investigators graded all adverse events and toxic effects according to the National Cancer Institute's Common Toxicity Criteria, version 4.03., through study completion, up to 1 year
This is a non-interventional study to observe the safety and efficiency of chemotherapy for potentially resectable locally advanced esophagogastric junction